IVPost
New materials improve delivery of therapeutic messenger RNA
- Details
- Written by Anne Trafton
- Category: Latest News
Cambridge, Massachusetts - In an advance that could lead to new treatments for a variety of diseases, MIT researchers have devised a new way to deliver messenger RNA (mRNA) into cells.
Sound researcher receives highest honor for decades of work in hearing science
- Details
- Written by IVP
- Category: Health News
Tempe, Arizona - We learn the basics of hearing sound waves, ear parts, and the effects of pitch and volume sometime around third grade, but there are still mysteries to unravel, including how we process where sounds are located, especially if there are a lot of different sounds at one time, or how we handle sounds that are moving.
FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
- Details
- Written by Sandy Walsh
- Category: Latest News
Washington, DC - The U.S. Food and Drug Administration approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. This is the first drug in its class (IDH1 inhibitors) and is approved for use with an FDA-approved companion diagnostic used to detect specific mutations in the IDH1 gene in patients with AML.
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency
- Details
- Written by IVPost
- Category: Medical News
Washington, DC - The U.S. Food and Drug Administration approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy. The FDA also approved Kisqali in combination with fulvestrant for the treatment of postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer, as initial endocrine based therapy or following disease progression on endocrine therapy.
UA Clinical Trial to Repurpose Ketamine for Parkinson’s Patients
- Details
- Written by IVP
- Category: Health News
Tucson, Arizona -The best-known treatment for Parkinson’s disease isn’t perfect. Named levodopa, the drug can treat the stiffness and slowness of movement associated with the debilitating disease.
Diabetes Emergency Relief Coalition Wins Top Association Honor
- Details
- Written by Michelle Kirkwood
- Category: Latest News
Orlando, Florida - The Diabetes Emergency Relief Coalition (Coalition), composed of leading diabetes care and research organizations, will receive the American Society of Association Executives (ASAE) 2018 Summit Power of A Award for helping to provide critical diabetes supplies to regions impacted by Hurricanes Harvey, Irma and Maria, the Coalition announced.
Page 4 of 50